IQVIA (NYSE:IQV) Price Target Lowered to $239.00 at JPMorgan Chase & Co.
IQVIA (NYSE:IQV – Free Report) had its target price reduced by JPMorgan Chase & Co. from $262.00 to $239.00 in a report released on Monday,...
JPMorgan Chase & Co. Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $10.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price decreased by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note issued...
Occidental Petroleum (NYSE:OXY) PT Lowered to $78.00 at JPMorgan Chase & Co.
Occidental Petroleum (NYSE:OXY – Free Report) had its target price decreased by JPMorgan Chase & Co. from $81.00 to $78.00 in a research report sent...
HC Wainwright Cuts Oncolytics Biotech (NASDAQ:ONCY) Price Target to $5.00
Oncolytics Biotech (NASDAQ:ONCY – Free Report) had its price objective cut by HC Wainwright from $15.00 to $5.00 in a research note published on Monday,...
HC Wainwright Cuts MacroGenics (NASDAQ:MGNX) Price Target to $12.00
MacroGenics (NASDAQ:MGNX – Free Report) had its price target trimmed by HC Wainwright from $14.00 to $12.00 in a research note issued to investors on...
Apogee Therapeutics (NASDAQ:APGE) Earns Outperform Rating from Wedbush
Wedbush reaffirmed their outperform rating on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a report released on Monday, RTT News reports. Wedbush currently...